High-dose alkylating agent therapy: a review of clinical experiences.

Abstract

Cancer Drug DeliveryVol. 1, No. 3 High-Dose Alkylating Agent Therapy: A Review of Clinical ExperiencesM.A. CORNBLEET, R.C.F. LEONARD, and J.F. SMYTHM.A. CORNBLEETSearch for more papers by this author, R.C.F. LEONARDSearch for more papers by this author, and J.F. SMYTHSearch for more papers by this authorPublished Online:2 Apr 2009https://doi.org/10.1089/cdd.1984.1.227AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byAlkylating Agents3 November 2010Application of hematopoietic progenitor assays for the estimation of hematotoxicity in ratsJournal of Pharmacological and Toxicological Methods, Vol. 31, No. 2A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patientsCancer Chemotherapy and Pharmacology, Vol. 29, No. 1Delivery of vital drugs to the brain for the treatment of brain tumorsJournal of Controlled Release, Vol. 11, No. 1-3Physicochemical and pharmacokinetic parameters of seven lipophilic chlorambucil esters designed for brain penetrationCancer Chemotherapy and Pharmacology, Vol. 25, No. 5Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the ratCancer Chemotherapy and Pharmacology, Vol. 27, No. 1Drug Delivery to the Brain by Blood-Brain Barrier Circumvention and Drug ModificationOptimizing drug delivery to brain tumorsCancer Treatment Reviews, Vol. 14, No. 1Melphalan concentration dependent plasma protein binding in healthy humans and ratsEuropean Journal of Clinical Pharmacology, Vol. 32, No. 2 Volume 1Issue 3Jan 1984 To cite this article:M.A. CORNBLEET, R.C.F. LEONARD, and J.F. SMYTH.High-Dose Alkylating Agent Therapy: A Review of Clinical Experiences.Cancer Drug Delivery.Jan 1984.227-238.http://doi.org/10.1089/cdd.1984.1.227Published in Volume: 1 Issue 3: April 2, 2009PDF download